Detailed price information for Rhythm Pharmaceuticals Inc (RYTM-Q) from The Globe and Mail including charting and trades.
New estimates say that Medicare will spend tens of billions of dollars over nine years to cover weight-loss drugs.
A new CDC report reveals that over 15.5 million U.S. adults have ADHD, with 71.5 per cent facing difficulties obtaining ...
Dr. Steven-Huy Han, a UCLA liver specialist, has prescribed Ocaliva to a handful of patients, although he’s not sure it helps ...
Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...